4.5 Review

Obesity, Diabetes, and Increased Cancer Progression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care

Nicolas J. Pillon et al.

Summary: This review focuses on the influence of genetic and environmental factors on metabolism and highlights the importance of personalized strategies for prevention, management, and care to improve health outcomes and reduce the impact of metabolic diseases.
Review Biochemistry & Molecular Biology

Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression

Duc-Vinh Pham et al.

Summary: Obesity is associated with increased risk of cancer, with adipokines playing a key role in modulating cancer cell metabolism. Leptin and other adipokines overproduced in obesity promote cellular metabolism, while adiponectin possesses anti-tumor activities. Adipokines may play a crucial role in the metabolic rewiring of cancer cells in the tumor microenvironment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies

Dunne Fong et al.

Summary: Cancer is a complex multistep process involving genetic and environmental factors leading to genetic and epigenetic changes. Cancer stem cells play a crucial role in tumor progression and are a subpopulation of tumor cells with self-renewal and differentiation abilities. Repurposing FDA-approved drugs to target resistant cancer cells, such as CSCs, can improve cancer treatment efficacy.

RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2021)

Article Biotechnology & Applied Microbiology

Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles

Chunai Gong et al.

Summary: A pH-responsive co-delivery platform was developed to target Met-facilitated PD-L1 degradation and siFGL1 delivery for FGL1 gene silencing, demonstrating high synergistic therapeutic efficacy against breast cancer.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Oncology

Obesity, Type 2 Diabetes, and Cancer Risk

Tiffany Scully et al.

Summary: Obesity and type 2 diabetes are both linked to increased cancer risk, with metabolic abnormalities playing a key role in the relationship and progression of cancer. Multiple mechanisms, including insulin signaling, lipid and glucose metabolism, as well as changes in adipose tissue, are proposed to be involved in the association between obesity, diabetes, and cancer.

FRONTIERS IN ONCOLOGY (2021)

Article Endocrinology & Metabolism

Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis

Ashwini Arvind et al.

Summary: This study found that thiazolidinediones may reduce the incidence of HCC in Asians with type 2 diabetes, while alpha-glucosidase inhibitors and sulfonylureas may slightly increase the risk of HCC. Future research should investigate whether these drugs should be avoided in patients with chronic liver disease.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Medicine, Research & Experimental

MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer

Wei-Jan Wang et al.

Summary: This study highlights that obesity is associated with increased risks and decreased survival in patients with GBC. Leptin plays a role in GBC growth and resistance to gemcitabine, possibly through the pSTAT3/CEBPD/MCL1 axis. Targeting this pathway may provide a new therapeutic strategy for improving gemcitabine efficacy in GBC patients.

JCI INSIGHT (2021)

Review Endocrinology & Metabolism

Review: Diabetes, Obesity, and Cancer-Pathophysiology and Clinical Implications

Iliana C. Lega et al.

ENDOCRINE REVIEWS (2020)

Review Endocrinology & Metabolism

Insulin-PI3K signalling: an evolutionarily insulated metabolic driver of cancer

Benjamin D. Hopkins et al.

NATURE REVIEWS ENDOCRINOLOGY (2020)

Article Biochemistry & Molecular Biology

Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer

Crystal C. Lipsey et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Cancer-associated adipocytes: emerging supporters in breast cancer

Chongru Zhao et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Review Medicine, Research & Experimental

Anticancer mechanisms of metformin: A review of the current evidence

Bin Zhao et al.

LIFE SCIENCES (2020)

Review Biochemistry & Molecular Biology

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy

Erik Henke et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Biochemistry & Molecular Biology

Adiponectin as Link Factor between Adipose Tissue and Cancer

Erika Di Zazzo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Adult weight gain accelerates the onset of breast cancer

Maria Azrad et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Review Biochemistry & Molecular Biology

Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease

Sheetal Parida et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

The oncogenic roles of 27-hydroxycholesterol in glioblastoma

Lu Liu et al.

ONCOLOGY LETTERS (2019)

Review Oncology

Cancer-associated adipocytes: key players in breast cancer progression

Qi Wu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Biochemistry & Molecular Biology

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

Xinming Jing et al.

MOLECULAR CANCER (2019)

Review Endocrinology & Metabolism

Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment

Sunghwan Suh et al.

DIABETES & METABOLISM JOURNAL (2019)

Review Oncology

Challenges and perspectives in the treatment of diabetes associated breast cancer

Samson Mathews Samuel et al.

CANCER TREATMENT REVIEWS (2018)

Review Pharmacology & Pharmacy

Metformin as an Anticancer Agent

Ales Vancura et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2018)

Review Endocrinology & Metabolism

Thiazolidinedione therapy and breast cancer risk in diabetic women: A systematic review and meta-analysis

Rui Du et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)

Article Physiology

Contribution of Adipose Tissue to Development of Cancer

Alyssa J. Cozzo et al.

COMPREHENSIVE PHYSIOLOGY (2018)

Article Biochemistry & Molecular Biology

Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins

Sandra Guaita-Esteruelas et al.

MOLECULAR CARCINOGENESIS (2017)

Review Geriatrics & Gerontology

27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator

Sisi He et al.

MATURITAS (2017)

Review Biochemistry & Molecular Biology

Adipocyte-Tumor Cell Metabolic Crosstalk in Breast Cancer

Andrew J. Hoy et al.

TRENDS IN MOLECULAR MEDICINE (2017)

Review Oncology

Role of tumor microenvironment in tumorigenesis

Maonan Wang et al.

JOURNAL OF CANCER (2017)

Review Biochemistry & Molecular Biology

The potential role of leptin in tumor invasion and metastasis

Amitabha Ray et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2017)

Review Oncology

Metformin targets multiple signaling pathways in cancer

Yong Lei et al.

CHINESE JOURNAL OF CANCER (2017)

Article Endocrinology & Metabolism

Mechanism of Metformin: A Tale of Two Sites

Ruisheng Song

DIABETES CARE (2016)

Article Oncology

Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2

Lan Wei et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)

Review Biotechnology & Applied Microbiology

Targeting adipose tissue in the treatment of obesity-associated diabetes

Christine M. Kusminski et al.

NATURE REVIEWS DRUG DISCOVERY (2016)

Review Oncology

Lipid metabolic reprogramming in cancer cells

S. Beloribi-Djefaflia et al.

ONCOGENESIS (2016)

Review Biochemistry & Molecular Biology

Pancreatic regulation of glucose homeostasis

Pia V. Roeder et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2016)

Review Physiology

OBESITY AND DIABETES: THE INCREASED RISK OF CANCER AND CANCER-RELATED MORTALITY

Emily Jane Gallagher et al.

PHYSIOLOGICAL REVIEWS (2015)

Review Endocrinology & Metabolism

Diabetes and cancer: two diseases with obesity as a common risk factor

S. K. Garg et al.

DIABETES OBESITY & METABOLISM (2014)

Review Endocrinology & Metabolism

Obesity and cancer-mechanisms underlying tumour progression and recurrence

Jiyoung Park et al.

NATURE REVIEWS ENDOCRINOLOGY (2014)

Review Physiology

Estrogen and Cancer

Jing Liang et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)

Article Endocrinology & Metabolism

The Links Between Insulin Resistance, Diabetes, and Cancer

Etan Orgel et al.

CURRENT DIABETES REPORTS (2013)

Article Biochemistry & Molecular Biology

Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer

Ana Chocarro-Calvo et al.

MOLECULAR CELL (2013)

Article Multidisciplinary Sciences

27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

Erik R. Nelson et al.

SCIENCE (2013)

Article Endocrinology & Metabolism

Beta Cell Dysfunction and Insulin Resistance

Marlon E. Cerf

Frontiers in Endocrinology (2013)

Review Endocrinology & Metabolism

The Role of Adiponectin in Cancer: A Review of Current Evidence

Maria Dalamaga et al.

ENDOCRINE REVIEWS (2012)

Article Gastroenterology & Hepatology

Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus

Chia-Hsuin Chang et al.

HEPATOLOGY (2012)

Review Biochemical Research Methods

Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders

Stefan Lehr et al.

PROTEOMICS CLINICAL APPLICATIONS (2012)

Review Endocrinology & Metabolism

Aromatase, breast cancer and obesity: a complex interaction

Serdar E. Bulun et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)

Article Biochemistry & Molecular Biology

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

Kristin M. Nieman et al.

NATURE MEDICINE (2011)

Review Immunology

Adipokines in inflammation and metabolic disease

Noriyuki Ouchi et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Article Endocrinology & Metabolism

Adipokines as novel biomarkers and regulators of the metabolic syndrome

Yingfeng Deng et al.

YEAR IN DIABETES AND OBESITY (2010)

Article Endocrinology & Metabolism

Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer

Michael Bodmer et al.

DIABETES CARE (2010)

Article Endocrinology & Metabolism

Adiponectin Represses Colon Cancer Cell Proliferation via AdipoR1-and-R2-Mediated AMPK Activation

A. Young Kim et al.

MOLECULAR ENDOCRINOLOGY (2010)

Article Biochemistry & Molecular Biology

Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling

Kandice R. Levental et al.

Review Endocrinology & Metabolism

Rosiglitazone and risk of cancer - A meta-analysis of randomized clinical trials

Matteo Monami et al.

DIABETES CARE (2008)

Review Biochemistry & Molecular Biology

Inflammation and insulin resistance

Carl de Luca et al.

FEBS LETTERS (2008)

Article Public, Environmental & Occupational Health

Cancer risks in thiazolidinedione users compared to other anti-diabetic agents

Carol Koro et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)

Review Endocrinology & Metabolism

Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones

AH Payne et al.

ENDOCRINE REVIEWS (2004)

Article Multidisciplinary Sciences

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

EV Jensen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Biochemistry & Molecular Biology

Ceramide glycosylation potentiates cellular multidrug resistance

YY Liu et al.

FASEB JOURNAL (2001)